Jag Capital Management LLC Sells 9,704 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Jag Capital Management LLC cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.8% in the fourth quarter, HoldingsChannel reports. The firm owned 32,798 shares of the medical equipment provider’s stock after selling 9,704 shares during the period. Intuitive Surgical comprises about 2.4% of Jag Capital Management LLC’s investment portfolio, making the stock its 13th largest holding. Jag Capital Management LLC’s holdings in Intuitive Surgical were worth $17,119,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $31,000. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Finally, Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $36,000. 83.64% of the stock is owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the transaction, the vice president now owns 473 shares in the company, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 12,598 shares of company stock worth $7,223,467 over the last quarter. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Down 1.1 %

Shares of ISRG opened at $566.98 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market capitalization of $201.95 billion, a price-to-earnings ratio of 88.45, a PEG ratio of 5.85 and a beta of 1.39. The stock’s 50-day moving average price is $570.66 and its 200-day moving average price is $530.08.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on ISRG shares. Stifel Nicolaus lifted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. UBS Group lifted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Evercore ISI lifted their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Truist Financial boosted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Finally, Piper Sandler restated an “overweight” rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.